Digital Aria Co Ltd (115450) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Digital Aria Co Ltd (115450) has a cash flow conversion efficiency ratio of -0.015x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-2.66 Billion ≈ $-1.80 Million USD) by net assets (₩176.02 Billion ≈ $119.28 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 115450 market cap for the company's overall valuation and market capitalisation.
Digital Aria Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)
This chart illustrates how Digital Aria Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Digital Aria Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Digital Aria Co Ltd ranked by their cash flow conversion efficiency. Explore Digital Aria Co Ltd (115450) cash flow quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Méliuz S.A
SA:CASH3
|
0.012x |
|
Yeong Hwa Meta
KO:012280
|
0.097x |
|
Cornish Metals Inc.
V:CUSN
|
-0.014x |
|
Dwi Guna Laksana Tbk PT
JK:DWGL
|
-0.045x |
|
John Hancock Income Securities Closed Fund
NYSE:JHS
|
0.026x |
|
Mnc Investama Tbk
JK:BHIT
|
0.006x |
|
NOVAREX Co.Ltd
KQ:194700
|
0.041x |
|
SAI SILKS (KALAMANDIR) LIMITED
NSE:KALAMANDIR
|
0.143x |
Annual Cash Flow Conversion Efficiency for Digital Aria Co Ltd (2011–2025)
The table below shows the annual cash flow conversion efficiency of Digital Aria Co Ltd from 2011 to 2025. View Digital Aria Co Ltd stock quote for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩173.86 Billion ≈ $117.82 Million |
₩-8.18 Billion ≈ $-5.54 Million |
-0.047x | -675.17% |
| 2024-12-31 | ₩157.46 Billion ≈ $106.71 Million |
₩1.29 Billion ≈ $872.70K |
0.008x | -57.84% |
| 2023-12-31 | ₩171.52 Billion ≈ $116.24 Million |
₩3.33 Billion ≈ $2.25 Million |
0.019x | +125.70% |
| 2022-12-31 | ₩116.71 Billion ≈ $79.09 Million |
₩-8.81 Billion ≈ $-5.97 Million |
-0.075x | +20.51% |
| 2021-12-31 | ₩118.68 Billion ≈ $80.43 Million |
₩-11.27 Billion ≈ $-7.64 Million |
-0.095x | +27.18% |
| 2020-12-31 | ₩89.35 Billion ≈ $60.55 Million |
₩-11.65 Billion ≈ $-7.90 Million |
-0.130x | -50.39% |
| 2019-12-31 | ₩63.94 Billion ≈ $43.33 Million |
₩-5.54 Billion ≈ $-3.76 Million |
-0.087x | -68.84% |
| 2018-12-31 | ₩68.66 Billion ≈ $46.53 Million |
₩-3.53 Billion ≈ $-2.39 Million |
-0.051x | +57.63% |
| 2017-12-31 | ₩38.44 Billion ≈ $26.05 Million |
₩-4.66 Billion ≈ $-3.16 Million |
-0.121x | -51.17% |
| 2016-12-31 | ₩33.88 Billion ≈ $22.96 Million |
₩-2.72 Billion ≈ $-1.84 Million |
-0.080x | +43.87% |
| 2015-12-31 | ₩30.08 Billion ≈ $20.39 Million |
₩-4.30 Billion ≈ $-2.91 Million |
-0.143x | +39.24% |
| 2014-12-31 | ₩22.52 Billion ≈ $15.26 Million |
₩-5.29 Billion ≈ $-3.59 Million |
-0.235x | -327.84% |
| 2011-12-31 | ₩18.38 Billion ≈ $12.46 Million |
₩1.90 Billion ≈ $1.29 Million |
0.103x | -- |
About Digital Aria Co Ltd
HLB Therapeutics Co.,Ltd., a biotech company, develops pharmaceutical products in South Korea and internationally. It is developing GBT-201 using Thymosin beta for the treatment of ophthalmic diseases, such as dry eye syndrome and neurotrophic keratopathy; and OKN-007 for the treatment of glioblastoma brain tumor. It is also involved in the wholesale of vaccines, as well as manufactures electrica… Read more